TETRALYSAL 300 ? – a product with pedigree from Galderma
Collis Williams
Collis Williams
Glymecycline 300mg – ONCE Daily, a convenient choice for today’s generation.
Tetralysal? is one of the few systemic products in the Galderma portfolio. It has gained a reputation in the acne market, in which two out of three patients are now treated with oral antibiotics. A member of the tetracycline family of antibiotics launched in the 1960’s, Tetralysal? has forged a solid reputation as a reliable, trouble-free treatment. Tetralysal? was launched recently with dermatologists in Malta offering a competitive solution in two of Galderma’s main therapeutic areas (acne and rosacea) as obvious complements to Differin? and Rozex? respectively.
Further Tetralysal? information from Collis Williams
Tel: 21 22 41 04, 21 24 48 47
Please login to access this information.
Tags
adoloscence
cancer
cannabis
Cardiology
Contributions
covid 19
dementia
Dermatology
Dermfest
Diabetes
Editorial
endocrinology
environmental health
exercise
Family Medicine
Francesco Carelli
gastroenterology
Geriatrics
gynaecology
hypertension
Infectious Diseases
Medical Education
Medical Ethics
Medicine and the arts
microbionta
Neurology
Nutrition
obesity
obstetrics
Oncology
Orthopaedics
Paediatrics
Pharmacology
Pharmacy Practice
pregnancy
Psychiatry
Public Health
Radiology
Respiratory Medicine
Rheumatology
smoking
Surgery
TheSynapse Interview
Urology
Women's health